Get the Stockscreener App
43.39
3.19%
1.34
After Hours:
43.50
0.11
+0.25%
Moderna Inc Stock (MRNA) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
94.06%
167.00
|
2,811.00 | 1,831.00 | 344.00 | 1,862.00 |
| Cost Of Revenue |
89.67%
96.00
|
929.00 | 2,241.00 | 731.00 | 792.00 |
| Gross Profit |
96.23%
71.00
|
1,882.00 | -410.00 | -387.00 | 1,070.00 |
Operating Expenses
|
28.73%
1,337.00
|
1,876.00 | 1,602.00 | 1,480.00 | 1,436.00 |
| Benefits Costs and Expenses |
51.40%
1,332.00
|
2,741.00 | 3,789.00 | 2,093.00 | 2,167.00 |
| Costs And Expenses |
48.91%
1,433.00
|
2,805.00 | 3,843.00 | 2,211.00 | 2,228.00 |
| Operating Income/Loss |
21,200%
-1,266.00
|
6.00 | -2,012.00 | -1,867.00 | -366.00 |
| Income/Loss Before Equity Method Investments |
1,394%
-1,152.00
|
89.00 | -1,925.00 | -1,784.00 | -287.00 |
| Income/Loss From Equity Method Investments |
31.58%
-13.00
|
-19.00 | -33.00 | 35.00 | -18.00 |
| Income/Loss From Continuing Operations Before Tax |
1,764%
-1,165.00
|
70.00 | -1,958.00 | -1,749.00 | -305.00 |
| Income Tax Expense/Benefit |
106.80%
10.00
|
-147.00 | 1,672.00 | -369.00 | -384.00 |
| Income/Loss From Continuing Operations After Tax |
641.47%
-1,175.00
|
217.00 | -3,630.00 | -1,380.00 | 79.00 |
|
Net Income/Loss
|
641.47%
-1,175.00
|
217.00 | -3,630.00 | -1,380.00 | 79.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
382.00
|
- | 381.00 | 381.00 | 386.00 |
| Diluted Average Shares |
382.00
|
- | 381.00 | 381.00 | 405.00 |
| Basic Earnings Per Share |
648.21%
-3.07
|
0.56 | -9.53 | -3.62 | 0.20 |
| Diluted Earnings Per Share |
648.21%
-3.07
|
0.56 | -9.53 | -3.62 | 0.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.30%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):